Log in to save to my catalogue

Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tiss...

Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tiss...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0f4a6a369307477087dddc35e4f25eb6

Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells

About this item

Full title

Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

Journal title

Stem cells international, 2019-01, Vol.2019 (2019), p.1-14

Language

English

Formats

Publication information

Publisher

Cairo, Egypt: Hindawi Publishing Corporation

More information

Scope and Contents

Contents

Aims. Induced pluripotent stem cell-derived cardiomyocytes (iPS-CMs) have become a promising tool in cardiovascular safety pharmacology. Immaturity of iPS-CMs remains an ongoing concern. We compared electrophysiological and contractile features of cardiac bodies (hiPS-CBs) derived from human-induced pluripotent stem cells and human neonatal and inf...

Alternative Titles

Full title

Different Responses to Drug Safety Screening Targets between Human Neonatal and Infantile Heart Tissue and Cardiac Bodies Derived from Human-Induced Pluripotent Stem Cells

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_0f4a6a369307477087dddc35e4f25eb6

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_0f4a6a369307477087dddc35e4f25eb6

Other Identifiers

ISSN

1687-966X,1687-9678

E-ISSN

1687-9678

DOI

10.1155/2019/6096294

How to access this item